Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Ramnicu Valcea

16 clinical trials in Ramnicu Valcea, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Ramnicu Valcea at a glance
16
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

16 trials in Ramnicu Valcea

Open in trial search
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Rheumatoid arthritis

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol Myers Squibb International Corporation

Psoriatic arthropathy

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Systemic scleroderma

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Sjogren's syndrome

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Resiniferatoxin
  • Sponsor:Gruenenthal GmbH

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Ramnicu Valcea

What the registry says about research in the country

01 Autoimmune Disorders

Innovative research focusing on Systemic Lupus Erythematosus (SLE) treatments, evaluating multiple novel therapeutic compounds including cenerimod and deucravacitinib for reducing disease activity and improving long-term patient outcomes.

  • SLE Management Studies
  • Long-term Safety Evaluations
  • Disease Activity Monitoring

Clinical investigations aim to establish new treatment standards for patients with moderate to severe disease manifestations.

02 Rheumatic Conditions

Comprehensive studies examining treatments for Psoriatic Arthritis and Juvenile Psoriatic Arthritis, including new biological therapies and innovative compounds for both adult and pediatric populations.

  • Adult PsA Treatment Studies
  • Pediatric Arthritis Research
  • Biologic Therapy Evaluation

Research focuses on reducing symptoms and improving quality of life across different age groups.

03 Inflammatory Disorders

Ground-breaking research into Sjögren's Syndrome and dermatomyositis, testing novel therapeutic approaches including sibeprenlimab and ianalumab for symptom management and disease control.

  • Inflammatory Disease Markers
  • Novel Treatment Approaches
  • Symptom Management Studies

Studies aim to advance understanding of inflammatory condition treatments and their long-term effectiveness.

04 Musculoskeletal Conditions

Advanced research examining osteoarthritis and axial spondyloarthritis, including innovative pain management solutions and disease-modifying treatments.

  • Pain Management Protocols
  • Joint Function Studies
  • Treatment Safety Assessments

Investigations focus on improving mobility and reducing pain in chronic musculoskeletal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.